Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Smoldering Multiple Myeloma × Watchful Waiting × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Oropharyngeal Neoplasms 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Retinoblastoma 1 Pleuropulmonary blastoma 1 Pelvic Neoplasms 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Leukemia, Myeloid, Acute 1 Epstein-Barr Virus Infections 1 Endometrial Neoplasms 1 Burkitt Lymphoma 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Anus Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1 Anal Canal Carcinoma 1

Interventions

daratumumab 2 Lenalidomide 2 poly ICLC 1 fludarabine phosphate 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 citarinostat 1 auricularum 1 PVX-410 vaccine 1 Diet, Mediterranean 1 Dexamethasone 1 Cyclophosphamide 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡